INTRODUCTION
============

Recent data suggest that approximately 1 110 000 men and women in the United States have a history of cancer of the colon and rectum.^[@B1]^ Colectomy, often used to treat colorectal cancer, can be performed by various techniques. An open approach is the most frequent, but laparoscopic techniques are also used and well accepted.^[@B2][@B3][@B4]^ The rate of laparoscopic techniques is increasing particularly in urban centers, in which laparoscopic colectomies are performed at a higher rate than in other settings.^[@B2],[@B3],[@B5],[@B6]^ Within the large Premier Hospital Database,^[@B7]^ from 2009 through the second quarter of 2011, approximately one-third of segmental colectomies (cecectomy, right hemicolectomy, left hemicolectomy, and sigmoidectomy) were identified as having a laparoscopic procedural code.

Laparoscopic techniques have minimized the perioperative morbidity associated with many types of surgery, including colectomy.^[@B8][@B9][@B10]^ Several prospective randomized trials have shown that laparoscopic colectomy has equivalent oncologic outcomes to the traditional open surgical approach. Additional advantages with regard to pain, blood loss, return of bowel function, length of hospitalization, and overall recovery time have been shown.^[@B11][@B12][@B15]^ Fewer postoperative complications have also been noted.^[@B16]^ In addition, resource use is lower for laparoscopic colectomy, including reduced length of stay, fewer readmissions, and less use of skilled nursing facilities.^[@B16],[@B17]^

Robotic-assisted surgery is an emerging approach in the field of laparoscopic colorectal surgery. Currently, there is only one commercially available robotic device cleared by the US Food and Drug Administration for laparoscopic procedures (da Vinci Surgical System; Intuitive Surgical, Sunnyvale, California). Several authors have published their experiences and case series related to robotic-assisted laparoscopic colectomy.^[@B18],[@B19]^ Although no specific large randomized controlled trials have evaluated robotic-assisted versus traditional laparoscopic colectomies, clinical outcomes suggest that robotic-assisted laparoscopic surgery is equivalent to conventional laparoscopy when considering important endpoints such as conversion to open surgery, hospital stay, and recovery time.^[@B20],[@B21]^

In this era of comparative effectiveness and health care reform in the United States, and with concerns about optimal resource utilization at the forefront, the use of robotic-assisted laparoscopic surgery deserves further evaluation. Given this background, this study examined clinical and economic outcomes (cost and utilization) in patients undergoing laparoscopic colectomy performed with and without robotic assistance.

MATERIALS AND METHODS
=====================

Data Source
-----------

The Premier Hospital Database was used as the data source for this study.^[@B7]^ This database contains complete patient billing, hospital cost, and coding histories from more than 600 health care facilities throughout the United States. The data from which this study was derived were extracted from more than 25 million inpatient discharges and 175 million hospital outpatient visits from acute care facilities, ambulatory surgery centers, and clinics across the nation.

A protocol describing the analysis objectives, criteria for patient selection, data elements of interest, and statistical methods was submitted to the New England Institutional Review Board, and exemption was obtained.

Eligible patients were aged ≥18 years and had undergone a laparoscopic colectomy during the period from 2009 to the second quarter of 2011. Patients were categorized according to the following 4 types of laparoscopic segmental colectomies: laparoscopic cecectomy (17.32), laparoscopic right hemicolectomy (17.33), laparoscopic left hemicolectomy (17.35), and laparoscopic sigmoidectomy (17.36). These procedures were chosen because the laparoscopic approach has been shown to have equivalent oncologic outcomes with documented perioperative morbidity benefits compared with open surgery. Other procedures, such as low anterior resection, where traditional laparoscopy has not yet been established to be equivalent to open surgery, were not included. Laparoscopic colectomy procedures using robotic technology were identified if one of two conditions was met: (1) a robotic *International Classification of Diseases, Ninth Edition* (ICD-9) procedure code accompanied the primary procedure code of interest or (2) "text" fields were found when mining the hospital charge master file for each patient indicating use of the robot.

For all eligible patients, elements describing hospital cost, surgery time, length of stay, use of the robot, colectomy type, and indication for colectomy were obtained from the data. Cost analysis (calculation) reflected the cost to the hospital for the colectomy procedures but did not include capital costs. This analysis was limited to the total cost per patient episode and did not break out costs at the level of disposables, operating room time, or other patient care costs. The specific cause of total cost differences was not formally evaluated. The preoperative All Patient Refined Diagnosis Related Groups severity level was used as an index of comorbidity. The 3M All Patient Refined Diagnosis Related Groups Classification System is a widely adopted proprietary risk-adjustment classification tool that uses information from routine claims data to produce valid and reliable severity measurement and risk-adjustment scores.^[@B22]^ It is used to account for differences related to an individual\'s severity of illness or risk of death in large datasets. Comorbid conditions that might influence procedure selection or outcomes of interest, such as the presence of cardiovascular or pulmonary disease, cancer, or diabetes mellitus, were obtained by use of ICD-9 diagnosis codes. Comorbid conditions were grouped into 11 categories based on the Medical Expenditure Panel Survey data lists: arthritis, malignant neoplasms, mental disorders, metabolic diseases, diseases of the digestive system, diseases of the genitourinary system, diseases of the circulatory system, diseases of the musculoskeletal system and connective tissue, diseases of the nervous system, diseases of the respiratory system, and diseases of the cutaneous system.^[@B23]^ **Appendix A** provides a detailed listing of all ICD-9 codes for each condition within each category. Information on sociodemographic characteristics and health insurance status was also included, as were descriptors of the care setting, namely census region, urban or rural setting, teaching hospital status, and facility bed count.

Adverse events identified by ICD-9 codes that occurred intraoperatively and ≤30 days postoperatively, which included pulmonary, cardiac, vascular, neurologic, and "other," were flagged and included in the analysis. The "other" category encompassed shock and perforations or fistulae of organs or vessels not included in the aforementioned organ systems. Minor and major bleeding was categorized by ICD-9 diagnosis as well as procedure codes related to hemorrhage and transfusions. A detailed list of each event and the corresponding ICD-9 code is found in **Appendix B**.

Each specific adverse event identified by ICD-9 code was organized as either major or minor categories based on clinical experience. These were then evaluated and characterized based on whether they were related to the surgical technique (bleeding, abscess, wound infection, and so on). Information on adverse events among matched data by analysis groups appears in **Appendix B**. Stoma procedures were identified and treated separately from the complications (**Appendix C**). Because of limitations of the dataset, it could not be determined whether these were planned stomas or due to a complication.

Statistical Analyses
--------------------

The study objective was to use the Premier Hospital Database to compare clinical and economic outcomes in patients undergoing laparoscopic colectomy with and without the use of robotic assistance. Outcomes of interest included adverse events (minor, major, and surgical), whether a stoma was performed, hospital costs, length of stay, and surgery time.

A "quasi-randomization" method for limiting bias called propensity scoring was used to create groups of analyzable patients who were well matched.^[@B24][@B25][@B26]^ Propensity scores were assigned based on likely predictors of the outcome of interest. Covariates on which to match were selected based on their availability in the Premier Hospital Database, as well as their general acceptance as factors associated with the outcomes of interest. The goal of this propensity matching analysis was to find pairs of patients receiving and not receiving a robotic laparoscopic colectomy who share like propensities for candidacy for the procedure based on the matching variables. An SAS macro from the Mayo Clinic used "nearest-neighbor matching" on the estimated propensity scores to choose matches for the patients who had a robotic procedure.^[@B27]^ Propensity scores were calculated for receipt of robotic procedures for each of the patients included in the analysis based on a nonparsimonious multivariable logistic regression model. Patients were matched on the following 13 characteristics: age, gender, race, insurance type, primary ICD-9 procedure code, region of facility, urban versus nonurban classification of facility, teaching status of facility, number of beds at facility, and presence or absence of 4 comorbid conditions that were shown to be statistically significant before matching---skin cancer, colon cancer, hyperlipidemia, and hypothyroidism. The robotic and nonrobotic patients were randomly ordered, and the nonrobotic patient with the propensity score closest to that of the first robotic patient was chosen. Finally, a 1:1 match was obtained for their specific colectomy procedure type. Assessment of residual bias was conducted by evaluating the differences in the distribution of patient characteristics before and after matching.

To assess the extent to which the propensity matching reduced confounders, the distributions of several variables before and after matching were compared---including age, gender, race, insurance type, health status, region, location, facility type, primary ICD-9 procedure code, comorbid conditions, and cancer versus noncancer---based on the top 10 most frequently occurring ICD-9 diagnosis codes among the patients in the cohorts. Group comparisons were made by use of *t* tests and χ^2^ tests after confirmation of approximately symmetric distribution of the variables and comparable variability before and after the match. We used *t* tests to test for differences between the matched cohorts in the 3 continuous variables of interest: hospital cost, surgery time, and length of stay. Logistic regression models were used to test for significant differences between the two groups and to generate odds ratios on the following categories of adverse events and complications: major, minor, and surgical and whether the patient also received a stoma. Residuals and Akaike information criterion were checked for goodness of fit of the logistic regression models. Analyses were performed with SAS, version 9.2 (SAS Institute, Cary, North Carolina).

RESULTS
=======

A total of 25 758 patient records from 364 hospitals were analyzed. The patient attrition process is shown in **[Table 1](#T1){ref-type="table"}**. Ninety-eight percent of all laparoscopic colectomies included in this analysis were performed without the use of robotic assistance (n = 25 210). Robotic assistance was used in 548 procedures, or approximately 2% of the total colectomies. The procedural breakdown was as follows: laparoscopic cecectomy, 12; right hemicolectomy, 203; left hemicolectomy, 42; and sigmoidectomy, 291 (**[Table 2](#T2){ref-type="table"}**).

###### 

Attrition Process

  Description                                                                                                                          No. of Patients Remaining   No. of Patients Dropped for Reason Listed
  ------------------------------------------------------------------------------------------------------------------------------------ --------------------------- -------------------------------------------
  Total patients in Premier Hospital Database 2009 Q1^[a](#TF1-1){ref-type="table-fn"}^ to 2011 Q2^[a](#TF1-1){ref-type="table-fn"}^   102 914 774                 
  Patients with primary procedure code for colectomy (17.32, 17.33, 17.35, 17.36)                                                      25 977                      102 888 797
  Patients aged ≥18 y at date of procedure                                                                                             25 883                      94
  Patients with inpatient visits only                                                                                                  25 758                      125

Q1 = first quarter; Q2 = second quarter.

###### 

Patient Demographics

                                                                        Robot            Nonrobot         *P* Value
  --------------------------------------------------------------------- ---------------- ---------------- -----------
  Total n (% of total N = 25 758)                                       548 (2.1)        25 210 (97.9)    
  Age \[mean (minimum-maximum)\]                                        61.36 (18--89)   62.08 (18--89)   .257
      18--40 y                                                          7.85             7.91             .493
      41--50 y                                                          15.33            13.19            
      51--60 y                                                          21.9             23.19            
      61--70 y                                                          26.09            25.03            
      71--80 y                                                          19.89            19.78            
      \>80 y                                                            8.94             10.91            
  Gender                                                                                                  
      Female                                                            54.2             53.09            .858
      Male                                                              45.8             46.91            
      Unknown                                                           0                0.01             
  Insurance type                                                                                          
      Government                                                        49.27            48.23            .543
      Managed care                                                      40.51            40.02            
      Other                                                             10.22            11.75            
  Race                                                                                                    
      White                                                             68.25            71.15            \<.001
      African American                                                  7.12             8.32             
      Hispanic                                                          12.41            5.00             
      Other                                                             12.23            15.53            
  Health status                                                                                           
      APR-DRG^[a](#TF2-1){ref-type="table-fn"}^ severity level 1 or 2   85.4             81.82            .031
      APR-DRG severity level 3 or 4                                     14.6             18.18            
  Primary ICD-9 procedure code                                                                            
      17.32 laparoscopic cecectomy                                      2.19             5.01             \<.001
      17.33 laparoscopic right hemicolectomy                            37.04            45.66            
      17.35 laparoscopic left hemicolectomy                             7.66             9.61             
      17.36 laparoscopic sigmoidectomy                                  53.10            39.73            
  Top 10 primary ICD-9 diagnosis codes                                                                    
      Diverticulitis, colon (562.11)                                    35.22            27.97            \<.001
      Neoplasm, benign large intestine (211.3)                          12.77            18.06            .001
      Neoplasm malignant ascending colon (153.6)                        9.49             10.38            .496
      Neoplasm malignant sigmoid colon (153.3)                          10.22            7.47             .016
      Neoplasm malignant cecum (153.4)                                  7.12             7.08             .974
      Diverticulitis, colon without hem (562.10)                        2.74             2.25             .451
      Neoplasm malignant hepatic flexure (153.0)                        2.01             1.98             .958
      Neoplasm malignant descending colon (153.2)                       1.28             1.62             .526
      Neoplasm malignant transverse colon (153.1)                       1.09             1.6              .348
      NEOP, UB, stomach/intestine (235.2)                               2.37             1.5              .096

APR-DRG = All Patient Refined Diagnosis Related Groups NEOP, UB = Neoplasm, Uncertain Behavior.

Before matching, distributions were similar for age, gender, insurance, and most primary diagnosis codes for patients in both groups (**[Table 2](#T2){ref-type="table"}**). Furthermore, few differences in comorbidities or illness severity index were noted between the robotic and nonrobotic groups. The characteristics of the 364 hospitals with colectomy procedures were similar with regard to census region and location (urban vs rural). There were notable differences, however, in teaching versus nonteaching and bed count, with most robotic procedures being performed in teaching hospitals with \>200 beds, as compared with nonrobotic procedures, with the majority coming from nonteaching hospitals with greater variation in bed size (**[Table 3](#T3){ref-type="table"}**). After matching, 1066 patients remained, with 533 patients in each group. Patient characteristics, comorbid conditions, and hospital characteristics after matching are represented in **[Table 4](#T4){ref-type="table"}**. After matching, patients were balanced with respect to demographics, comorbid conditions, and hospital characteristics, with the exception of hospital location (urban vs nonurban), which was statistically significantly different between the two groups (*P* = .017).

###### 

Hospital Demographics Based on Patient Counts

                                    Robot Patients   Nonrobot Patients
  --------------------------------- ---------------- -------------------
  Total n (% of total N = 25 758)   548 (2.1)        25 210 (97.9)
  Census region (%)                                  
      Northeast                     30.11            20.13
      West                          8.94             21.31
      South                         56.02            41.49
      Midwest                       4.93             17.08
  Location (%)                                       
      Urban                         98.72            91.55
      Nonurban                      1.28             8.45
  Type (%)                                           
      Teaching                      64.6             36.46
      Non-teaching                  35.4             63.54
  Bed count (%)                                      
      ≤50                           0.00             0.65
      51--100                       0.73             3.17
      101--200                      1.64             10.09
      \>200                         97.63            86.09

###### 

Matched Cohorts

                                                                        Robot           Nonrobot       *P* Value
  --------------------------------------------------------------------- --------------- -------------- -----------
  Total n                                                               533             533            
  Age \[mean (SD)\]                                                     61.09 (14.19)   61.2 (13.95)   .903
      18--40 y                                                          7.88            8.63           .943
      41--50 y                                                          15.57           14.07          
      51--60 y                                                          22.14           22.70          
      61--70 y                                                          26.45           27.77          
      71--80 y                                                          19.51           19.51          
      \>80 y                                                            8.44            7.32           
  Gender                                                                                               
      Female                                                            53.85           54.22          .902
      Male                                                              46.15           45.78          
  Insurance type                                                                                       
      Government                                                        48.41           49.16          .574
      Managed care                                                      41.28           42.40          
      Other                                                             10.32           8.44           
  Race                                                                                                 
      White                                                             68.29           66.42          .861
      African American                                                  7.32            7.50           
      Hispanic                                                          11.82           13.51          
      Other                                                             12.57           12.57          
  Health status                                                                                        
      APR-DRG^[a](#TF4-1){ref-type="table-fn"}^ severity level 1 or 2   85.18           87.43          .285
      APR-DRG severity level 3 or 4                                     14.82           12.57          
  Region                                                                                               
      Northeast                                                         30.96           27.02          .400
      West                                                              9.19            8.07           
      South                                                             54.78           59.66          
      Midwest                                                           5.07            5.25           
  Location                                                                                             
      Urban                                                             98.69           96.44          .017
      Nonurban                                                          1.31            3.56           
  Facility type                                                                                        
      Teaching                                                          63.60           62.66          .751
      Nonteaching                                                       36.40           37.34          
  Comorbid conditions                                                                                  
      Arthritis                                                                                        
          Rheumatoid arthritis                                          1.69            1.13           .435
          Psoriatic arthritis                                           0.00            0.75           .157
          Ankylosing spondylitis                                        0.38            0.00           .045
      Malignant neoplasms                                                                              
          Skin cancer                                                   0.00            0.00           NA
          Colon cancer                                                  12.57           12.95          .854
          Lung, bronchus, or trachea                                    0.19            0.38           .563
      Diseases of digestive system                                                                     
          GERD^[a](#TF4-1){ref-type="table-fn"}^                        12.57           13.13          .784
          Gastritis                                                     5.25            6.00           .595
          Gastric ulcer                                                 0.56            0.94           .478
          Crohn disease                                                 1.13            1.31           .780
          Ulcerative colitis                                            0.56            0.38           .654
          Diverticulitis of colon                                       24.58           23.26          .615
      Disease of genitourinary system                                                                  
          Kidney stones                                                 2.25            0.94           .087
          Cystitis                                                      1.31            0.75           .363
      Mental disorders                                                                                 
          Depressive disorders                                          6.94            6.57           .807
          Neurotic disorders                                            4.32            4.32           \<.999
      Diseases of circulatory system                                                                   
          Coronary artery disease                                       11.44           9.94           .428
          Heart failure                                                 3.56            4.32           .529
          MI^[a](#TF4-1){ref-type="table-fn"}^ (any)                    3.56            3.19           .735
          Stroke                                                        0.75            0.94           .738
          Cardiac dysrhythmias                                          8.82            9.94           .529
          Hypertension                                                  31.71           33.02          .647
      Diseases of musculoskeletal system and connective tissue                                         
          Irritable bowel syndrome                                      1.50            2.06           .487
          Lumbar disk disease                                           1.50            2.81           .140
          Osteoporosis                                                  4.69            2.81           .107
          Osteoarthritis                                                6.75            7.88           .480
      Diseases of nervous system                                                                       
          Parkinson disease                                             0.00            0.75           .045
          Multiple sclerosis                                            0.38            0.00           .157
          Migraine                                                      2.06            1.69           .652
      Diseases of respiratory system                                                                   
          Chronic bronchitis                                            0.94            1.69           .282
          Emphysema                                                     0.38            1.31           .094
          Asthma                                                        5.63            6.00           .794
          COPD^[a](#TF4-1){ref-type="table-fn"}^                        4.88            5.63           .583
      Diseases of skin                                                                                 
          Eczema (dermatitis)                                           0.56            0.00           .083
          Sebaceous gland diseases                                      0.19            0.19           \<.999
      Metabolic diseases                                                                               
          Diabetes                                                      13.51           11.07          .225
          Hyperlipidemia                                                20.26           19.70          .818
          Hypothyroidism                                                7.88            7.32           .729
  Primary ICD-9 procedure code                                                                         
      17.32: laparoscopic cecectomy                                     2.06            2.06           \<.999
      17.33: laparoscopic right hemicolectomy                           36.77           36.77          
      17.35: laparoscopic left hemicolectomy                            7.69            7.69           
      17.36: laparoscopic sigmoidectomy                                 53.47           53.47          
  Cancer diagnosis                                                                                     
      Cancer                                                            30.77           27.58          .284
      Non-cancer                                                        53.66           55.91          

APR-DRG = All Patient Refined Diagnosis Related Groups; COPD = chronic obstructive pulmonary disease; GERD = gastroesophageal reflux disease; MI = myocardial infarction; NA = Not Applicable.

After matching, clinical endpoints and adverse events occurring in the postoperative period ≤30 days after discharge were tabulated and grouped into 4 categories: major, minor, surgical, and stoma related. Complications (major, minor, and surgical) and stoma procedures were not significantly different between the robotic and nonrobotic surgery cohorts, regardless of whether they were examined within a perioperative 30-day period or only within the original perioperative hospital stay (**[Table 6](#T6){ref-type="table"}**).

###### 

Hospital Costs, Surgery Time, and Length of Stay After Matching

                        Robot    Nonrobot   *P* Value
  --------------------- -------- ---------- -----------
  Total n               533      533        
  Hospital costs (\$)                       
      Mean              17 445   15 448     .001
      SD                9435     9875       
      Median            15 010   12 883     
  Surgery time (h)                          
      Mean              4.37     3.34       \<.001
      SD                1.55     1.31       
      Median            4.00     3.00       
  Length of stay (d)                        
      Mean              5.74     6.09       .344
      SD                6.13     6.10       
      Median            4.00     4.00       

###### 

Adverse Events After Matching

                                                      Odds Ratio Estimate   Lower CI^[a](#TF6-1){ref-type="table-fn"}^   Upper CI   *P* Value
  --------------------------------------------------- --------------------- -------------------------------------------- ---------- -----------
  During hospital stay or 30-d follow-up                                                                                            
      Major^[b](#TF6-2){ref-type="table-fn"}^         0.942                 0.729                                        1.217      .648
      Minor^[c](#TF6-3){ref-type="table-fn"}^         0.827                 0.617                                        1.109      .205
      Surgical^[d](#TF6-4){ref-type="table-fn"}^      0.945                 0.737                                        1.212      .656
      Enterostomy^[e](#TF6-5){ref-type="table-fn"}^   1.038                 0.609                                        1.77       .892
  During hospital stay only                                                                                                         
      Major                                           0.905                 0.694                                        1.179      .458
      Minor                                           0.752                 0.552                                        1.025      .071
      Surgical                                        0.859                 0.665                                        1.108      .242
      Enterostomy                                     1.00                  0.578                                        1.729      \<.999

CI = confidence interval.

Major: acute respiratory failure, spontaneous tension pneumothorax, atelectasis/pulmonary collapse, empyema, bronchopleural fistula, air leak and other pneumothorax, chylothorax, pneumonia, other pulmonary infections and inflammation, acute myocardial infarction, acute heart failure/pulmonary edema, acute pulmonary embolism/infarction, acute deep venous thrombosis of extremities, acute cerebrovascular accident (stroke), transient cerebral ischemia/transient ischemic attack, intracranial hemorrhage (includes hemorrhagic stroke), dehiscence, perforations of organ or vessels, in-hospital death, sepsis, other postoperative complications, accidental puncture or laceration during procedure, other postoperative infection, peritoneal abscess, other retroperitoneal abscess, abscess of intestine, fistula of intestine, excluding rectum and anus, ureteral fistula, intestinoureteral fistula, intestinovesical fistula, digestive--genital tract fistula, female, persistent postoperative fistula, other specified intestinal obstruction, unspecified intestinal obstruction, intestinal or peritoneal adhesions with obstruction (postoperative), peritonitis (acute), generalized, other suppurative peritonitis, other retroperitoneal infections, unspecified peritonitis, iatrogenic pulmonary embolism and infarction.

Minor: hematoma/seroma complicating procedure, cellulitis, other postoperative infection, including other (non-cellulitis) wound infection, other digestive system complications, paralytic ileus, perioperative autologous transfusion of whole blood or blood components, transfusion of previously collected autologous blood, other transfusion of whole blood, transfusion of packed cells, hemorrhage complicating procedure, hematoma complicating procedure.

Surgical: chylothorax, dehiscence, hematoma/seroma complicating procedure, cellulitis, other postoperative infection, including other (non-cellulitis) wound infection, perforations of organ or vessels, in-hospital death, sepsis, other postoperative complications, other digestive system complications, paralytic ileus, accidental puncture or laceration during procedure, other postoperative infection, peritoneal abscess, other retroperitoneal abscess, abscess of intestine, fistula of intestine, excluding rectum and anus, ureteral fistula, intestinoureteral fistula, intestinovesical fistula, digestive--genital tract fistula, female, persistent postoperative fistula, other specified intestinal obstruction, unspecified intestinal obstruction, intestinal or peritoneal adhesions with obstruction (postoperative), peritonitis (acute), generalized, other suppurative peritonitis, other retroperitoneal infections, unspecified peritonitis, perioperative autologous transfusion of whole blood or blood components, transfusion of previously collected autologous blood, other transfusion of whole blood, transfusion of packed cells, hemorrhage complicating procedure, hematoma complicating procedure.

Enterostomy: colostomy and enterostomy complication unspecified, infection of colostomy or enterostomy, mechanical complication of colostomy or enterostomy, other complication of colostomy or enterostomy, exteriorization of large intestine, colostomy, not otherwise specified, temporary colostomy, permanent colostomy, exteriorization of small intestine, ileostomy, not otherwise specified, temporary ileostomy, continent ileostomy, other permanent colostomy, other enterostomy.

Cohorts were also tested for differences in average hospital costs, surgery time, and length of stay (**[Table 5](#T5){ref-type="table"}**). The average length of stay of the two cohorts was not statistically different (5.74 days for robotic vs 6.09 days for nonrobotic, *P* = .344). The inpatient surgery time was significantly longer for robotic-assisted procedures (4.37 hours; 95% confidence interval \[CI\], 4.24--4.51 hours) than for nonrobotic procedures (3.34 hours; 95% CI, 3.23--3.46 hours) (*P* \< .001). Hospital costs were substantially higher for robotic-assisted laparoscopic colectomy than for procedures without robotic assistance (\$17 445 vs \$15 448, *P* = .001).

DISCUSSION
==========

This study showed that in a real-world setting, one-third of all segmental colectomies are performed by a minimally invasive approach, the vast majority without robotic assistance (98%). When well-matched cohorts are compared, the results of laparoscopic colectomy with and without robotic assistance are similar with respect to clinical outcomes (length of stay) and when considering perioperative complications. Robotic-assisted procedures were associated with higher hospital costs and longer surgery times.

The findings related to higher hospital costs associated with robotic surgery are consistent with similar studies in the literature evaluating other laparoscopic surgical procedures. Although there is a difference in hospital charges versus costs, charges are directly correlated to costs, and the trend is still the same, with robotic surgery consistently costing more. For example, Rodgers et al^[@B28]^ compared the cost of robotic-assisted tubal reanastomosis with mini-laparotomy and also found that the cost of the robotic procedure was higher, with a median cost difference of \$1446 (95% CI, \$1112--\$1812; *P* \< .001). This is a consistent finding among other surgery types.^[@B29],[@B30]^ Although not all of these studies examined colectomies specifically, these results do provide directional understanding of cost comparisons for other robotic-assisted minimally invasive procedures.

Two other clinical studies have directly compared robotic-assisted and laparoscopic left- and right-sided colectomies (**[Table 7](#T7){ref-type="table"}**). Rawlings et al^[@B30]^ found an increase in mean operative time, similar mean length of stay, and similar mean total hospital cost for right-sided colectomies. The reported comparison for sigmoid colectomies showed a similar mean operative time, mean length of stay, and mean total hospital cost. In a retrospective review, Deutsch et al^[@B20]^ showed similar means for operative time and length of stay. There was a difference in operative time and a similar length of stay for left-sided colectomies.

###### 

Right and Left Colectomies: Operative Parameters

                                 Right-Sided Laparoscopic   Right-Sided Robotic   *P* Value for Right Side   Left-Sided Laparoscopic   Left-Sided Robotic   *P* Value for Left Side
  ------------------------------ -------------------------- --------------------- -------------------------- ------------------------- -------------------- -------------------------
  Rawlings et al^[@B30]^                                                                                                                                    
      No. of patients            15                         17                                               13                        12                   
      Operative time (min)       169.2 ± 37.5               218.9 ± 44.6          .002                       199.4 ± 44.5              225 ± 37.1           .128
      Length of stay             5.5 ± 3.4                  5.2 ± 5.8             .862                       6.6 ± 8.3                 6 ± 7.3              .854
      Total hospital cost (\$)   8073 ± 2805                9255 ± 5075           .430                       10 697 ± 11 719           12 335 ± 12 162      .735
  Deutsch et al^[@B20]^                                                                                                                                     
      No. of patients            47                         18                                               44                        61                   
      Operative time (min)       214.4 ± 63.2               219.2 ± 39.2          .7529                      254.7 ± 53.3              289.7 ± 61.8         .0006
      Length of stay             6.3 ± 6.4                  4.3 ± 2.5             .1328                      4.2 ± 1.2                 4.1 ± 1.5            .7067
  Premier data                                                                                                                                              
      No. of patients            207                        207                                              326                       326                  
      Operative time (min)       179 ± 64.2                 247 ± 90              \<.001                     213.6 ± 84                272.4 ± 93.6         \<.001
      Length of stay             6.93 ± 7.22                6.46 ± 7.41           .515                       5.56 ± 5.20               5.28 ± 5.12          .485
      Total hospital cost (\$)   16 396 ± 12 497            18 515 ± 9803         .057                       14 845 ± 7724             16 772 ± 9147        .004

Data are shown as mean ± SD.

In this Premier dataset, before matching for right- and left-sided procedures, the right-sided procedures showed a significant difference in operative time and a similar length of stay. The left-sided procedures also showed a difference in operative time and a similar length of stay. For both robotic and traditional cases, there was a considerable reporting difference between the reported operative time and length of stay of the retrospective cases series by Deutsch et al^[@B20]^ and Rawlings et al^[@B30]^ compared with those reported in the Premier dataset. This may reflect the differences between a single site, surgeon and hospital learning curves, and heterogeneity in patient populations. Further analysis around the clinical and economic outcome differences between aggregated payor reporting database outcomes and historic single-center series may provide future insight into the complexities of clinical outcomes research, especially when assessing new and evolving technologies.

In highly complex or technically challenging cases, robotic technology may offer the potential for advancing minimally invasive surgery. However, this research indicates that the traditional laparoscopic approach achieves similar clinical outcomes for segmental colon resections at a significantly decreased cost to the hospital. Although subsequent generations of robotic technology may represent the future, economically, it is difficult to justify the uptake in robotic surgery for procedures such as routine colectomies.

Important strengths of this analysis included the prospectively developed protocol that directed the analysis, the quasi-randomization propensity scoring methodology that was used, the broad geographic and demographic representation of US hospitals included in the sample, and the fact that these data are relatively recent and represent the real-world setting. This study also had some noteworthy limitations. Because the data were mined from a hospital administrative database used for billing purposes, certain data points were unable to be captured or could not be clearly identified. Examples include body mass index, patient behaviors such as smoker versus nonsmoker, and complications resulting in an unplanned enterostomy or specific complications related to anastomotic leaks. Enterostomies could not be identified as being planned or related to some complication and thus were evaluated separately from complications. Because there is no specific ICD-9 code for "anastomotic complication," this analysis had to rely on existing diagnosis codes, which often result from anastomotic complications but are not exclusive or specific. Furthermore, data regarding the precision of robotic versus nonrobotic procedures, including surgical margins and adequacy of lymph node dissection, could not be evaluated. The analysis was limited to a 30-day perioperative period, which limits analysis related to long-term survival or potential long-term complications. Other limitations of this analysis include lack of comparison between rates of conversion to an open approach and differentiation between hand-assisted and total laparoscopic approaches. However, these limitations are inherent to the data source and could be rationalized to impact both cohorts similarly. As a result, the risk of bias in one cohort is lessened. Finally, surgeon and institutional learning curve relative to using robotic technology could not be evaluated.

CONCLUSION
==========

This study represents the most up-to-date and expansive analysis of cost and effectiveness outcomes associated with robotic-assisted laparoscopic segmental colectomy in a real-world setting. These findings show few clinical differences in perioperative adverse events. Coupled with the increased per-case cost of the robot and increased operative times, the results suggest that further consideration is warranted before using this technology for segmental laparoscopic colectomies when standard laparoscopic means yielding comparable results are available. Future studies evaluating cost relative to robotic-assisted case volume and prospective randomized controlled studies focusing on comparative effectiveness between traditional and robotic-assisted laparoscopic segmental colectomy procedures are needed.

###### 

Comorbid Conditions

  Condition                                                  ICD-9 Diagnosis Codes
  ---------------------------------------------------------- -------------------------------------------------------------------------
  Arthritis                                                  
      Rheumatoid arthritis                                   714.0
      Psoriatic arthritis                                    696.0
      Ankylosing spondylitis                                 720.0
  Malignant neoplasms                                        
      Skin cancer                                            176.0, 209.31--209.36, 172.x, 173.x
      Colon cancer                                           153.x
      Lung, bronchus, or trachea                             162.x
  Diseases of digestive system                               
      GERD^[a](#TFA1-1){ref-type="table-fn"}^                530.81
      Gastritis                                              535.xx (except 535.6x)
      Gastric ulcer                                          531.xx
      Crohn disease                                          555.xx
      Ulcerative colitis                                     556.xx
      Diverticulitis                                         562.11, 562.13
  Disease of genitourinary system                            
      Kidney stones                                          592.0
      Cystitis                                               595.xx
  Mental disorders                                           
      Depressive disorders                                   311, 300.4, 309.0, 309.1, 309.28, 298.0, 296.2x, 296.3x, 296.4x, 296.5x
      Neurotic disorders                                     300.xx (without 300.4) + 309.81
  Diseases of circulatory system                             
      Coronary artery disease                                414.0x, 414.2, 414.3
      Heart failure                                          398.91, 402.x1, 404.x1, 404.x3, 428.xx
      MI^[a](#TFA1-1){ref-type="table-fn"}^ (any)            410.x1, 410.x2, 412
      Stroke                                                 430, 431, 432.x, 433.x1, 434.x1, 997.02
      Cardiac dysrhythmias                                   427.xx
      Hypertension                                           401.x, 402.xx, 404.xx, 405.xx
  Diseases of musculoskeletal system and connective tissue   
      Irritable bowel disease                                564.1
      Lumbar disk disease                                    722.10, 722.73, 722.52, 722.93
      Osteoporosis                                           733.0x
      Osteoarthritis                                         721.x, 715.xx
  Diseases of nervous system                                 
      Parkinson disease                                      332.x
      Multiple sclerosis                                     340
      Migraine                                               346.xx
  Diseases of respiratory system                             
      Chronic bronchitis                                     491.xx
      Emphysema                                              492.x
      Asthma                                                 493.xx
      COPD^[a](#TFA1-1){ref-type="table-fn"}^                491.x (except 491.0), 492.x, 493.2x, 494.x, 496
  Diseases of skin                                           
      Eczema (dermatitis)                                    692.9
      Sebaceous gland diseases                               706.x
  Metabolic diseases                                         
      Diabetes                                               249.xx, 250.xx
      Hyperlipidemia                                         272.4
      Hypothyroidism                                         243, 244.x

COPD = chronic obstructive pulmonary disease; GERD = gastroesophageal reflux disease; MI = myocardial infarction.

###### 

Adverse Events, Codes, and Counts of Major, Minor, and Surgical Complications

  Type             Description of Event                                                                                                   ICD-9 Code                                                                            Robot   No Robot           
  ---------------- ---------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ------- ---------- ------- -------
  Major            Acute respiratory failure                                                                                              518.81, 518.84, 518.5                                                                 2.81    3.19       3.00    3.19
  Major            Spontaneous tension pneumothorax                                                                                       512.0                                                                                 0.00    0.00       0.00    0.00
  Major            Atelectasis/pulmonary collapse                                                                                         518.0                                                                                 4.32    4.88       4.69    5.07
  Major            Empyema                                                                                                                510.9                                                                                 0.00    0.00       0.00    0.00
  Major            Bronchopleural fistula                                                                                                 510.0                                                                                 0.00    0.00       0.00    0.00
  Major            Air leak and other pneumothorax                                                                                        512.1, 512.8                                                                          0.38    0.38       0.19    0.19
  Major            Pneumonia                                                                                                              480.x to 486, 507.0                                                                   2.25    3.56       1.50    1.88
  Major            Other pulmonary infections and inflammation                                                                            487.0, 490, 491.21--491.22, 511.0--511.1, 511.89, 511.9, 513.x, 519.01                1.13    1.88       1.88    3.19
  Major            Acute myocardial infarction                                                                                            410.xx                                                                                1.31    1.50       0.75    0.94
  Major            Acute heart failure/pulmonary edema                                                                                    428.1, 428.21, 428.23, 428.31, 428.33, 428.41, 428.43, 514, 518.4                     0.19    0.38       0.38    0.38
  Major            Acute pulmonary embolism/infarction                                                                                    415.1x                                                                                0.38    0.75       0.38    0.75
  Major            Acute deep venous thrombosis of extremities                                                                            453.4x, 453.8, 453.9                                                                  1.13    1.50       0.56    0.75
  Major            Acute cerebrovascular accident (stroke)                                                                                433.x1, 434.x1, (997.02)                                                              0.00    0.00       0.00    0.00
  Major            Transient cerebral ischemia/transient ischemic attack                                                                  435.x, 437.1                                                                          0.00    0.00       0.19    0.38
  Major            Intracranial hemorrhage (includes hemorrhagic stroke)                                                                  430--432.x                                                                            0.00    0.00       0.00    0.00
  Major/surgical   Chylothorax                                                                                                            457.8                                                                                 0.00    0.00       0.00    0.00
  Major/surgical   Dehiscence                                                                                                             998.30, 998.31, 998.32, 998.3                                                         0.75    1.50       0.19    0.56
  Major/surgical   Perforations of organ or vessels                                                                                       998.2                                                                                 1.50    1.50       1.69    1.69
  Major/surgical   Sepsis                                                                                                                 038.xx, 790.7, 995.9x                                                                 1.88    2.63       1.69    2.06
  Major/surgical   Other postoperative complications                                                                                      997.xx except 997.02, 998.0, 998.11, 998.33, 998.4, 998.6, 998.7, 998.8x, and 998.9   10.13   11.63      11.63   13.70
  Major/surgical   Accidental puncture or laceration during procedure                                                                     998.2                                                                                 1.50    1.50       1.69    1.69
  Major/surgical   Peritoneal abscess                                                                                                     567.22                                                                                1.69    2.25       0.94    1.31
  Major/surgical   Other retroperitoneal abscess                                                                                          567.38                                                                                0.00    0.19       0.00    0.00
  Major/surgical   Abscess of intestine                                                                                                   569.5                                                                                 4.69    4.69       6.19    6.19
  Major/surgical   Fistula of intestine, excluding rectum and anus, intestinal or peritoneal adhesions with obstruction (postoperative)   569.81                                                                                0.94    0.94       0.56    0.75
  Major/surgical   Ureteral fistula, intestinoureteral fistula                                                                            593.82                                                                                0.00    0.00       0.00    0.00
  Major/surgical   Intestinovesical fistula                                                                                               596.1                                                                                 1.88    2.06       0.94    0.94
  Major/surgical   Digestive--genital tract fistula, female                                                                               619.1                                                                                 0.94    0.94       0.94    1.13
  Major/surgical   Persistent postoperative fistula                                                                                       998.6                                                                                 0.19    0.38       0.00    0.19
  Major/surgical   Other specified intestinal obstruction                                                                                 560.89                                                                                2.06    2.25       2.63    3.19
  Major/surgical   Unspecified intestinal obstruction                                                                                     560.9                                                                                 1.50    2.25       2.06    2.44
  Major/surgical   Peritonitis (acute), generalized                                                                                       567.21                                                                                0.38    0.38       0.38    0.38
  Major/surgical   Other suppurative peritonitis                                                                                          567.29                                                                                0.56    0.56       0.38    0.38
  Major/surgical   Other retroperitoneal infections                                                                                       567.39                                                                                0.00    0.00       0.00    0.00
  Major/surgical   Unspecified peritonitis                                                                                                567.9                                                                                 0.19    0.38       0.19    0.19
  Minor/surgical   Hematoma/seroma complicating procedure                                                                                 998.12--998.13, 998.51                                                                1.31    2.25       0.94    1.88
  Minor/surgical   Cellulitis                                                                                                             998.59 plus 682.2                                                                     2.06    4.32       2.63    3.38
  Minor/surgical   Other postoperative infection, including other (noncellulitis) wound infection                                         998.59 when 510.9, 510.0, 038.xx, 790.7, 995.9x, 682.2 are not also present           0.75    1.88       1.13    1.88
  Minor/surgical   Paralytic ileus                                                                                                        560.1                                                                                 9.01    9.19       10.51   11.44
  Minor/surgical   Other digestive system complications                                                                                   997.49                                                                                0.00    0.00       0.00    0.00
  Minor/surgical   Perioperative autologous transfusion of whole blood or blood components                                                99.00                                                                                 0.00    0.00       0.00    0.00
  Minor/surgical   Transfusion of previously collected autologous blood                                                                   99.02                                                                                 0.00    0.00       0.00    0.00
  Minor/surgical   Other transfusion of whole blood                                                                                       99.03                                                                                 0.00    0.00       0.00    0.00
  Minor/surgical   Transfusion of packed cells                                                                                            99.04                                                                                 7.88    9.57       11.63   12.01
  Minor/surgical   Hemorrhage complicating procedure                                                                                      998.11                                                                                0.75    1.31       1.88    2.44
  Minor/surgical   Hematoma complicating procedure                                                                                        998.12                                                                                1.13    1.50       0.75    1.13

###### 

Enterostomy Codes and Counts

  Type          Description of Event                                  ICD-9 Code   Robot   No Robot          
  ------------- ----------------------------------------------------- ------------ ------- ---------- ------ ------
  Enterostomy   Colostomy and enterostomy complication, unspecified   569.60       0.00    0.00       0.00   0.00
  Enterostomy   Infection of colostomy or enterostomy                 569.61       0.00    0.00       0.00   0.00
  Enterostomy   Mechanical complication of colostomy or enterostomy   569.62       0.00    0.00       0.38   0.38
  Enterostomy   Other complication of colostomy or enterostomy        569.69       0.00    0.19       0.19   0.19
  Enterostomy   Exteriorization of large intestine                    46.03        0.38    0.38       0.19   0.19
  Enterostomy   Colostomy, not otherwise specified                    46.10        2.25    2.44       2.44   2.44
  Enterostomy   Temporary colostomy                                   46.11        0.38    0.38       1.31   1.31
  Enterostomy   Permanent colostomy                                   46.13        0.38    0.38       0.00   0.00
  Enterostomy   Exteriorization of small intestine                    46.01        0.94    1.13       0.75   0.75
  Enterostomy   Ileostomy, not otherwise specified                    46.20        0.56    0.56       0.38   0.38
  Enterostomy   Temporary ileostomy                                   46.21        0.00    0.00       0.19   0.38
  Enterostomy   Continent ileostomy                                   46.22        0.00    0.00       0.00   0.00
  Enterostomy   Other permanent colostomy                             46.23        0.19    0.19       0.00   0.00
  Enterostomy   Other enterostomy                                     46.39        0.19    0.19       0.00   0.00
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